《大行》野村升科伦博泰(06990.HK)目标价至544.42元 肺癌数据鼓舞

阿斯达克财经
May 26

野村发表报告指出,科伦博泰(06990.HK) 将于即将举行的2026年美国临床肿瘤学会(ASCO)年会上,公布其TROP-2 ADC药物sac-TMT的OptiTROP-Lung05临床试验结果。该项III期试验针对PD-L1阳性非小细胞肺癌(NSCLC)患者,数据显示,sac-TMT联合pembrolizumab相比单用pembrolizumab,显著改善了无进展生存期(PFS),风险比(HR...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10